BACKGROUND Recent guidelines recommend assessment of systolic function and filling pressures to augment
CAV is a chronic graft complication caused by immune and nonimmune processes (2) (3) (4) . Earlier studies showed that factors such as donor age, recipient age, human leukocyte antigen (HLA) mismatch, allosensitization, frequent cellular rejection, and rejection with hemodynamic compromise are associated with increased risk of CAV in children (1, (5) (6) (7) (8) .
Single-center studies and a large collaborative retrospective analysis of the PHTS (Pediatric Heart Transplant Study) demonstrate that CAV is an important complication with a steady increase in prevalence over time. Rates of angiographically identified disease increase from 5% at 1 year to 15% by 5 years and to as much as 30% by 10 years post-transplant (6) . Analysis of outcomes after initial diagnosis of disease have been limited, with registry data demonstrating a 20% to 40% graft loss by 6 to 10 years after discovery (1, 6 ) and very little data reflecting the rate of graft loss stratified by disease severity.
In an attempt to define CAV for clinicians more clearly, the International Society for Heart and Lung Transplantation (ISHLT) released an updated set of nomenclature guidelines in 2010 (9) . Important changes in this update included the addition of measures of systolic and diastolic graft function to the angiographic assessment of CAV. These additional metrics are designed to increase sensitivity to microvascular disease and consequent myocardial fibrosis, which cannot be well described by angiography. Although these recommendations were built around adult experience and data (10) , the guidelines suggest application to pediatric patients, even though similar data and analyses in children are limited to small, single-center experiences (11, 12) .
This study sought to evaluate the validity of the ISHLT nomenclature guidelines in a large pediatric patient cohort and to examine the impact of functional assessment added to angiographic grading on the identification of patients at risk for death or retransplantation. We hypothesized that: 1) the addition of assessments of systolic performance by ejection fraction (EF) and diastolic filling by hemodynamic measurement would identify patients with less severe angiographic disease at increased risk for graft loss; and 2) the hemodynamic cutpoints proposed in the guidelines may not be sufficiently sensitive to discriminate graft dysfunction in younger patients. To test these hypotheses, we retrospectively graded the degree of vasculopathy in the patients followed through the PHTS dataset by using a combination of angiographic data, markers of systolic dysfunction, and restrictive filling and compared rates of graft loss with those found using an angiography-alone grading system. 
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A U G U S T 4 , 2 0 1 5 : 5 4 7 -5 7 since the inception of the PHTS. Although the data forms have evolved over time, they provide specific information about the presence and degree of stenosis in major and minor coronary vessels, the pattern of coronary artery dominance, and whether the lesion appears in the proximal, middle, or distal third of the artery. To determine the grade of CAV in each patient, all submitted angiogram forms were analyzed, and the angiographic criteria were applied according to the most recent ISHLT guidelines (9) . In this manner, an angiographic score of CAV-1, CAV-2, or CAV-3 was created for each patient ( Table 1) .
SYSTOLIC FUNCTION AND HEMODYNAMIC ASSESSMENT.
In addition to angiographic data, these forms also include the indication for the study, the EF and When EF values or hemodynamic values were not available, these patients were audited from those aspects of this study involving functional analysis.
RESULTS
PATIENT POPULATION. Our analysis included 3,120 pediatric heart transplant recipients from 1993 to 2009. Angiography was commonly performed; 2,078 (67%) patients had at least 1 angiogram, and a total of 8, 122 angiograms were performed in the study cohort. For patients surviving 2, 5, and 10 years post-transplant, the rate of coronary angiography rose from 61% to 83% to 98%, respectively, with most programs reporting routine assessments annually or every other year. Most of these studies (96%) were done with a reported indication of "routine per protocol," with Branch vessels: distal one-third of any primary vessels or any segment within a large septal perforator, diagonal, and obtuse marginal branches or any portion of a nondominant right coronary artery. If any functional abnormality is present in combination with CAV-1 or CAV-2 angiographic changes, the patient is "upgraded" to CAV-3.
CAV ¼ cardiac allograft vasculopathy; CI ¼ cardiac index; EF ¼ ejection fraction; LM ¼ left main coronary artery.
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showed severe systolic dysfunction with EF <30%
( Table 2) . A lower EF correlated with more severe angiographic disease (p < 0.0001), in which no adjustment was made for multiple observations.
Patients with a normal coronary angiogram (CAV-0)
rarely had an EF of <45% (2.8%), whereas patients with severe angiographic disease (CAV-3) had an EF <45% in 16.1% of angiograms ( Table 2) .
HEMODYNAMIC ASSESSMENT. Hemodynamic data were reported for 7,787 of 8,122 (95.9%) angiograms.
For 58.0% of angiograms, hemodynamic variables were collected within 3 months of angiography and were therefore included in the following analyses.
Using the previously described cutpoints for restrictive physiology, 1.2% of angiograms were associated with abnormal hemodynamic measurements. Of those, 0.7% had severely elevated RAP (>20 mm Hg), and 0.6% had marked elevation of PCWP (>25 mm Hg). Values are n (%). *N ¼ 4,565 angiograms with ejection fractions reported, p < 0.0001.
Abbreviations as in Table 1 .
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angiographic vasculopathy and an EF <45% had significantly worse graft survival than did patients with an EF >45% (p ¼ 0.0009) (Figure 2A ). There was no difference, however, between patients with moderate systolic dysfunction (EF 30% to 44%) and those with severe dysfunction (EF <30%).
Kaplan-Meier analysis of graft loss for patients after the initial diagnosis of any degree of Values are n (%). *N ¼ 4,714 angiograms with hemodynamics reported with 3 months of angiogram (RAP p < 0.0001; PCWP p < 0.0001).
RAP ¼ right atrial pressure; PCWP ¼ pulmonary capillary wedge pressure; other abbreviations as in Table 1 . Kindel et al.
A rejection with hemodynamic compromise) in these patients (7, 8) . Furthermore, children undergoing heart transplant tend to have less obesity, diabetes, hyperlipidemia, and hypertension than do typical adult transplant recipients, thus creating a healthier host environment for graft longevity (2,3).
In addition to seeing disease less frequently, most disease that was discovered was mild, as reported previously (6) . The current data, however, now include 3 times as many patients with at least 1 angiogram and significantly more patients with outcomes of death or retransplantation, thus allowing for a more robust analysis of these events. The lack of severe disease is again likely multifactorial, representing the quality of donors (younger age, lack of donor hypertension, diabetes, hyperlipidemia, or coronary disease), the low rates of significant rejection in children after heart transplant, and the otherwise healthy milieu of the pediatric transplant recipient. In addition, the coronary artery changes in these children may be more subtle than in adults, and detection may be challenged by practitioners' experience, vessel size, and other unknown factors (15-17). The PHTS only recently began collecting graded data for intravascular ultrasound, and the study does not contain data on cardiac computed tomography or cardiac magnetic resonance, which could have offered additional views into the degree of disease. However, these modalities are not routinely used in most pediatric centers at this time and are currently undergoing study as potential adjunctive means to identify CAV.
Therefore, the analysis of angiographic findings is quite applicable to current pediatric practice. Kindel et al.
Although moderate or severe vasculopathy is uncommon, when it is discovered the outcomes are quite severe. With greater patient numbers than in earlier series, we were able to examine moderate and severe angiographic disease separately, and a striking gradient effect was demonstrated (Figures 3 and 4) .
Mild CAV suggests a rather benign outcome with survival rates comparable to general outcomes for children after heart transplant. In contrast, moderate angiographic disease alone (without hemodynamic assessment) correlates with a higher rate of graft loss, with 50% of patients dead or undergoing repeat heart transplantation by 2 years and 67% by 5 years after discovery. Severe angiographic disease portends a very poor prognosis; 75% of children experience graft loss within 3 years of the initial diagnosis.
The available data from earlier registry reviews reported graft loss without delineation of disease severity (1) or stratified by angiographic grading (6).
The current study aimed to go further and includes 
